Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increasing dermal perfusion after burning by decreasing thromboxane production

M C Robson, E J DelBeccaro, J P Heggers

    The Journal of Trauma
    |September 1, 1980
    PubMed
    Summary

    In burns, thromboxane (TxA2) contributes to progressive dermal ischemia. Inhibiting thromboxane production in burned guinea pig skin improved dermal perfusion and potentially limited skin necrosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A review of the lupus problem.

    University of Durham medical gazette·2010
    Same author

    Owner's perception of carboplatin in conjunction with other palliative treatments for cancer therapy.

    The Journal of small animal practice·2010
    Same author

    The use of amnion-derived cellular cytokine solution to improve healing in acute and chronic wound models.

    Eplasty·2008
    Same author

    Hypochlorous acid as a potential wound care agent: part I. Stabilized hypochlorous acid: a component of the inorganic armamentarium of innate immunity.

    Journal of burns and wounds·2007
    Same author

    Current attitudes to, and use of, peri-operative analgesia in dogs and cats by veterinarians in New Zealand.

    New Zealand veterinary journal·2005
    Same author

    Pancreatic cyst in a cat.

    New Zealand veterinary journal·2005

    Area of Science:

    • Burn research
    • Wound healing
    • Dermal pathophysiology

    Background:

    • Progressive dermal ischemia post-burn can exacerbate skin necrosis.
    • Prostaglandins and thromboxanes are implicated in burn-induced dermal ischemia.
    • Several agents are known to prevent dermal ischemia, hinting at specific molecular pathways.

    Purpose of the Study:

    • To investigate the role of specific arachidonic acid metabolites, particularly thromboxane A2 (TxA2), in progressive dermal ischemia following burns.
    • To evaluate the efficacy of thromboxane inhibitors in mitigating dermal ischemia and improving dermal perfusion in burned tissues.

    Main Methods:

    • Utilized immunoperoxidase staining with specific antibodies to detect prostaglandins (PgE2, PgF2 alpha, PgI2) and thromboxane A2 (TxA2) in burned guinea pig skin biopsies.

    Related Experiment Videos

  • Employed Xenon-133 washout studies to quantify dermal perfusion in burned and unburned areas, both untreated and treated with thromboxane inhibitors (imidazole, methimazole, dipyridamole).

    • Main Results:

    • Burned guinea pig skin exhibited elevated levels of prostaglandin E2 (PgE2) and thromboxane A2 (TxA2).
    • Xenon-133 washout studies revealed prolonged tissue half-life (indicating reduced perfusion) in untreated burned areas, which significantly decreased following treatment with thromboxane inhibitors.
    • Immunohistochemical analysis of treated tissues showed a marked reduction or absence of TxA2, while levels of PgE2, PgF2 alpha, and PgI2 remained comparable to untreated controls.

    Conclusions:

    • Thromboxane A2 (TxA2) appears to be a key mediator of progressive dermal ischemia after thermal injury.
    • Inhibition of thromboxane production is an effective strategy to restore dermal perfusion and may limit the extent of skin necrosis in burn injuries.